Avagliano Mark
SEC insider (Form 3/4/5 filer). CIK 0001783503. Chief Business Officer at G1 Therapeutics, Inc. (GTHX). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2024. Located in RESEARCH TRIANGLE PARK, NC.
Companies Avagliano Mark has filed insider reports for
- G1 Therapeutics, Inc. (GTHX): Officer, Chief Business Officer
Avagliano Mark
CIK: 0001783503
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GTHX
G1 Therapeutics, Inc.
Officer